This paper proposes an original method for assessing costs of medical treatment. It defines states in a semi-Markov model associated with specific costs of the treatment, and not with patients' health statuses. Costs assigning to these "costs states" is more straightforward; moreover, it allows...

The use of price instruments is often advocated by economists, based on their ability to bring about marginal abatement cost equalisation, and hence to achieve targets at least cost. We use the EU ETS as a case study and test this theoretical prediction. We parametrically estimate separate...